Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06807840 · ClinicalTrials.gov registry record
Flu Infection at UPHS
A clinical trial of Influenza, Human, sponsored by University of Pennsylvania.
- Recruiting
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT06807840 is a study of Influenza, Human that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 50 participants, below the 16,221-participant average among 18 other Influenza, Human trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06807840, a study of Influenza, Human, is actively recruiting participants, sponsored by University of Pennsylvania.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Cellular and humoral immune responses in individuals with active influenza infection will be assessed. Each year, up to 50 participants will be enrolled. The investigators hypothesize that influenza infection will elicit mostly memory immune responses rather than de novo immune responses to infection.
Conditions Studied
Interventions
- OTHER influenza virus infection
Study Locations (1)
Pennsylvania
- Penn Presbyterian Medical Center - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-01-27 |
| Est. Completion | 2026-09-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06807840
The ClinicalTrials.gov registry entry for NCT06807840 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 16,221-participant average among 18 other Influenza, Human trials with a reported enrollment target (100% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Influenza, Human appearing as the primary indexed condition, and to 1 intervention - of which influenza virus infection is the first listed.
NCT06807840 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06807840 about?
NCT06807840 is a clinical study titled "Flu Infection at UPHS". Cellular and humoral immune responses in individuals with active influenza infection will be assessed. Each year, up to 50 participants will be enrolled. The investigators hypothesize that influenza infection will elicit mostly memory immune responses rather than de novo immune responses to infectio...
What is the current status of trial NCT06807840?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2025-01-27. Estimated completion is 2026-09-30.
What conditions does trial NCT06807840 study?
This clinical trial studies the following conditions: Influenza, Human.
What interventions are being tested in trial NCT06807840?
The interventions under investigation include: influenza virus infection (OTHER).
Who is sponsoring clinical trial NCT06807840?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06807840 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Influenza, Human
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Evaluate the Immune Response and Safety of an Influenza Vaccine in Adults 18 Years of Age and Above
RECRUITING · Phase 2
-
Characterization of Humoral and Cellular Immune Responses Elicited by Influenza Vaccination in Healthy Adults
RECRUITING · Phase 4
-
A Study to Assess the Immune Response and Safety of a Vaccine Against Influenza in Adults 18 Years of Age and Older
ACTIVE NOT RECRUITING · Phase 2
-
A Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an Adjuvanted Influenza Vaccine Compared to a Non-adjuvanted Influenza Vaccine in Adults ≥65 Years of Age
ACTIVE NOT RECRUITING · Phase 3
-
A Study to Evaluate the Bioequivalence of Over-encapsulated Oseltamivir Capsules to Marketed Oseltamivir Capsules in Healthy Volunteers
COMPLETED · Phase 1
-
Immunologic Response to FluMist vs. Flucelvax
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.